# The Effect of Alga Dunaliella Bardawil on Psoriasis

> **NCT01628081** · PHASE3 · UNKNOWN · sponsor: **Sheba Medical Center** · enrollment: 46 (estimated)

## Conditions studied

- Psoriasis

## Interventions

- **DIETARY_SUPPLEMENT:** Alga Dunaliella Bardawil placebo
- **DIETARY_SUPPLEMENT:** Dunaliella Bardawil

## Key facts

- **NCT ID:** NCT01628081
- **Lead sponsor:** Sheba Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-06
- **Primary completion:** 2014-06
- **Final completion:** 2014-07
- **Target enrollment:** 46 (ESTIMATED)
- **Last updated:** 2012-06-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01628081

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01628081, "The Effect of Alga Dunaliella Bardawil on Psoriasis". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT01628081. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*